NRX Pharmaceuticals Files 8-K on Financials
Ticker: NRXPW · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1719406
| Field | Detail |
|---|---|
| Company | Nrx Pharmaceuticals, INC. (NRXPW) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, regulation-fd, company-name-change
Related Tickers: NRXP
TL;DR
NRXP filed an 8-K on March 17th detailing financials and operations.
AI Summary
NRX Pharmaceuticals, Inc. filed an 8-K on March 21, 2025, reporting on results of operations, financial condition, and Regulation FD disclosures as of March 17, 2025. The filing includes financial statements and exhibits, with the company incorporated in Delaware and formerly known as Big Rock Partners Acquisition Corp. until October 12, 2017.
Why It Matters
This 8-K filing provides crucial updates on NRX Pharmaceuticals' financial performance and regulatory disclosures, which are important for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or significant new risks.
Key Players & Entities
- NRX Pharmaceuticals, Inc. (company) — Registrant
- Big Rock Partners Acquisition Corp. (company) — Former company name
- March 17, 2025 (date) — Date of earliest event reported
- March 21, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing for NRX Pharmaceuticals, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, Regulation FD Disclosure, and to file Financial Statements and Exhibits.
What was NRX Pharmaceuticals, Inc. formerly known as?
NRX Pharmaceuticals, Inc. was formerly known as Big Rock Partners Acquisition Corp.
When did the company change its name from Big Rock Partners Acquisition Corp.?
The company changed its name on October 12, 2017.
What is the state of incorporation for NRX Pharmaceuticals, Inc.?
The company is incorporated in Delaware.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported is March 17, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding NRX Pharmaceuticals, Inc. (NRXPW).